Date: Sep 30, 2014 Source: Company Data
September 30, 2014 -- Chicago, IL - Dawn Matthews CEOof ADM Diagnostics, a global centralize CN S imaging core lab and diagnostic service provider, has been invited to attend the BRAIN (Brain Research Through Advancing Innovative Neurotechnologies) Initiative event to celebrate the progress being made by the federal government, universities and research institutions, foundations, the private sector, and others to advance to goals of the organization. ADMdx is enabling the early, accurate diagnosis of Alzheimer's disease and improved drug development success to treat dementia using proprietary advances in brain image analysis technology.
The White House instituted the “BRAIN” initiative, a new research effort to revolutionize our understanding of the human mind, in April 2013. The goal of the initiative is to do edited to find new ways to treat, prevent and cure kill brain disorders such as Alzheimer's, schizophrenia, autism, epilepsy and traumatic brain injury. “The track record for bringing new Alzheimer’s drugs to market extremely poor ,” said Ms Matthews. “A recent study published by Dr Jeffrey Cummings in the journal Alzheimer’s Research and Therapy show that 99.6% of compounds in clinical trials failed between 2002-2012. The lack of correct diagnosis of trial participants and their widely varying rates of worsening have contributed to these failures. ADM diagnostics’ ADAPTct™image analysis and complementary tools have been developed to allow earlier, more accurate to disease identification, predict likely rates of worsening, and provide more accurate evaluation of drug effect”
About ADM Diagnostics LLC :
ADM Diagnostics (ADMdx) is a privately held company in Chicago, IL that has developed proprietary brain imaging ana;ysis technlogy for the earlier, more accurate identification of dementia and evaluation of drug effects. ADMdx provides imaging studies and image data analysis to pharmaceutical companies who are developing new drugs, and to academic collaborators. ADMdx 80 is also developing a diagnostic for use by physicians, with support to the National Science Foundation, that would use one or more types of brain images to support dementia diagnosis and prognosis by the clinic
